Home
    Disclaimer
    πŸ§ͺ This is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.

    1P-LSD

    Aliases: 1p, 1plsd

    Summary TheDrug.Wiki TripSit PsychonautWiki

    1P-LSD is a research chemical and LSD analogue that first appeared in 2015. It acts as a prodrug for LSD, being rapidly metabolized into LSD in the body, with effects reported as virtually indistinguishable from LSD itself. Typically sold on blotter paper.

    Perspectives

    “It is hypothesized that 1P-LSD is a prodrug to LSD, meaning that they would be functionally indistinguishable in vivo. An enjoyable and valuable substance with subtle but distinguishable differences from LSD.”

    “I have experienced so many beautiful moments, and I believe learned much, through the use of this remarkable drug. Mild aftereffects are well worth enduring, given the perceived positives and benefits.”

    Dose Information TheDrug.Wiki TripSit PsychonautWiki

    ROA Light Common Strong Heavy
    Oral 25-75Β΅g 75-150Β΅g 150-300Β΅g 300Β΅g+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit PsychonautWiki

    ROA Onset Comeup Peak Offset After Effects Total
    Oral 19-60 min 0.75-2 hrs 3-5 hrs 3-5 hrs 6-24 hrs 8-12 hrs

    Effect Profile

    143 reports

    Scores (1–10) curated from multiple sources:

    • Effect keyword matching from PsychonautWiki catalog
    • Validated against 112 Erowid trip reports
    • Weighted by importance: core (×3), major (×2), minor (×1)

    Full methodology

    Psychedelic 8.8
    Intense+ 9/10

    Strong visuals, headspace, auditory effects, and body load

    Visual Intensity ×3
    10
    external hallucinations internal hallucinations color enhancement autonomous entities drifting tracers +11 more
    Headspace Depth ×3
    10
    conceptual thinking introspection feelings of interdependent opposites recursion emotion enhancement feelings of self-design +7 more
    Auditory Effects ×1
    10
    auditory distortion auditory enhancement auditory hallucinations auditory hallucination synaesthesia
    Body Load / Somatic Effects ×1
    10
    nausea vasoconstriction muscle tension muscle spasms increased heart rate

    Tolerance

    Build-up develops rapidly after a single use
    Reset 7–14 days for baseline

    Tolerance Decay

    Full tolerance 1d Half tolerance 7d Baseline ~14d

    Rapid within‑session tachyphylaxis; re‑dosing the same day yields little additional effect. Substantial decay by ~7 days; near‑baseline at ~14 days for most, though individual variability exists.

    Cross-Tolerances

    Effects Erowid Bluelight

    Aggregated from 112 Erowid and 31 Bluelight experience reports

    Positive Effects 73

    Visual Distortions 68.5% 82%
    Color Enhancement 65.7% 88%
    Music Enhancement 54.5% 88%
    Stimulation 42.7% 80%
    Empathy 38.5% 85%
    Euphoria 36.4% 89%
    Introspection 35.7% 83%
    Focus Enhancement 33.6% 80%
    Tactile Enhancement 30.8% 85%
    Closed-Eye Visuals 30.0% 92%
    Joy 22.6% 84%
    Geometric Imagery 22.6% 87%
    Body High 20.3% 81%
    Visual Trails 19.4% 89%
    Awe 19.4% 80%
    Surface Breathing 16.1% 85%
    Patterning 16.1% 88%
    Insight 16.1% 76%
    Morphing 16.1% 83%
    Contentment 16.1% 79%

    Adverse Effects 55

    Anxiety 51.0% 84%
    Confusion 38.4% 86%
    Thought Disorganization 29.0% 74%
    Auditory Effects 28.7% 85%
    Fear 25.8% 88%
    Dissociation 19.6% 85%
    Panic 19.4% 85%
    Nausea 18.9% 82%
    Muscle Tension 18.9% 75%
    Sedation 18.9% 80%
    Body Load 16.1% 82%
    Memory Suppression 15.4% 76%
    Depersonalization 12.9% 84%
    Entity Imagery 12.9% 82%
    Insomnia 12.9% 88%
    Thought Loops 12.6% 83%
    Headache 9.8% 80%
    Restlessness 9.7% 78%
    Motor Impairment 9.1% 78%
    Sweating 8.4% 80%

    Combinations TripSit

    Trip Reports Effect Index

    Helpful Links